Apontis Pharma AG (APPH.DE)

EUR 10.05

(0.0%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019
Revenue 36.96 Million 55.72 Million 51.18 Million 39.24 Million 40.03 Million
Cost of Revenue 40.3 Million 20.73 Million 17.39 Million 14.21 Million 11.06 Million
Gross Profit -3.33 Million 34.99 Million 33.78 Million 25.02 Million 28.97 Million
Operating Expenses 23.17 Million 31.17 Million 32.12 Million 25.63 Million 31.21 Million
Selling, General and Administrative Expenses 6.41 Million 5.06 Million 4.6 Million 3.54 Million 4.64 Million
Research and Development Expenses - - - - -
Other Expenses 16.75 Million 2.2 Million 1.93 Million 2.19 Million 945.99 Thousand
Cost and Expenses 52.49 Million 51.91 Million 49.51 Million 39.85 Million 42.27 Million
Operating Income -15.1 Million 5.66 Million 1.67 Million -609.42 Thousand -2.24 Million
Interest Expense 71 Thousand 48 Thousand 406 Thousand 868 Thousand 828 Thousand
Income Tax Expense -3.54 Million 1.13 Million 993.52 Thousand -294.73 Thousand -678 Thousand
Earnings before Tax -14.84 Million 3.82 Million 248.26 Thousand -1.47 Million -3.07 Million
Net Income -11.3 Million 2.68 Million -745.23 Thousand -1.18 Million -2.39 Million
Earnings Per Share Basic -1.33 0.32 -0.09 -0.14 -0.28
Earnings Per Share Diluted -1.33 0.32 -0.09 -0.14 -0.28
Weighted Average Shares Outstanding 8.5 Million 8.5 Million 8.5 Million 8.5 Million 8.5 Million
Weighted Average Shares Outstanding (Diluted) 8.5 Million 8.5 Million 8.5 Million 8.5 Million 8.5 Million
Gross Margin -0.09 0.63 0.66 0.64 0.72
EBIT Margin -0.35 0.10 0.07 0.03 -0.04
Profit Margin -0.31 0.05 -0.01 -0.03 -0.06
EBITDA -12.94 Million 5.67 Million 1.99 Million 1.04 Million -1.67 Million
Earnings Before Tax Margin -0.41 0.10 0.03 -0.02 -0.06

Income Statement Charts